ABCB7 and liver disorder: Significant differences were found between CLD and cirrhosis patients in several biomarkers and scores, as outlined in Table 6, including APRI (p-value < 0.001), FIB-4 (p-value < 0.001), ASAT/ALAT ratio (p-value < 0.001), and NFS (p-value < 0.001), with cirrhosis patients showing higher values, indicating more advanced liver disease.